LIXTE Biotechnology Steps into Next-Gen Cancer Treatment with Liora Acquisition
LIXTE Biotechnology bought Liora Technologies to get the LiGHT System, a cutting-edge, high-precision proton therapy for cancer treatment.
LIXTE Biotechnology bought Liora Technologies to get the LiGHT System, a cutting-edge, high-precision proton therapy for cancer treatment.
ZIM Integrated Shipping launches a strategic review after receiving a preliminary buyout proposal from CEO Eli Glickman and Rami Ungar, with "multiple parties" expressing interest.
DICK'S (DKS) Q3 GAAP net income plunged 67% due to Foot Locker costs. The retailer plans $500M-$750M in charges to "clean out the garage" and shutter stores
Abercrombie & Fitch hiked its fiscal 2025 profit forecast to 10.20−10.50 after Q3 net sales reached $1.29B. Strong Hollister demand, resilient affluent spending, and an NFL partnership boost success.
Best Buy raises its annual sales and profit outlook after strong Q3 results, boosted by demand for laptops, smartphones, and gaming devices.
Kohl's (KSS) Q3 earnings crush analyst estimates with $0.10 EPS vs expected -$0.18. Revenue hits $3.4B, guidance raised to $1.25-$1.45 for full year.